Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $57 | $70 | $31 |
| Short-Term Investments | $248 | $77 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $0 |
| Total Curr. Assets | $310 | $151 | $31 |
| Property Plant & Equip (Net) | $5 | $4 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $0 |
| Total NC Assets | $5 | $5 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $315 | $155 | $32 |
| Liabilities | – | – | – |
| Payables | $2 | $3 | $1 |
| Short-Term Debt | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $6 | $0 |
| Total Curr. Liab. | $9 | $9 | $2 |
| LT Debt | $1 | $1 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $171 | $0 |
| Total NC Liab. | $1 | $172 | $10 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $0 |
| Total Liabilities | $10 | $181 | $12 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $30 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$124 | -$45 | -$11 |
| AOCI | -$1 | $0 | $0 |
| Other Equity | $430 | $20 | $1 |
| Total Equity | $305 | -$26 | $20 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $315 | $155 | $32 |
| Net Debt | -$55 | -$68 | -$21 |